TABLE 5.

Prevalence of carbapenem resistance in Acinetobacter spp. in various parts of the world

RegionPeriodSettingResistance (%)Reference
ImipenemMeropenem
North America
    15 centers2002-2004Nonduplicate clinical isolates8.36.578
    24 centers2001Non-ICU isolates6.110.435
    15 centers2006All isolates335340
South America
    25 centers2002-2004Nonduplicate clinical isolates28.128.578
    7 countries2001Nonduplicate clinical isolates16.318.173
Europe
    48 centers2002-2004Nonduplicate clinical isolates30.226.978
    37 centers1997-2000Nonduplicate clinical isolates161477
Asia/Pacific, 2 centers2002-2004Nonduplicate clinical isolates1.26.078
Australia1999-2004Nonduplicate clinical isolates111178